Differential Diagnosis for Chronic Lower Extremity Muscle Stiffness

Life-Threatening and High-Morbidity Conditions

The American College of Rheumatology suggests that juvenile dermatomyositis (JDM) is the most common idiopathic inflammatory myopathy in adolescents, with 25.5% of all cases having childhood onset 1, 2, 3
The European League Against Rheumatism (EULAR) recommends looking for proximal muscle weakness, skin manifestations such as heliotrope rash, Gottron's papules, or Gottron's sign, and symmetric involvement of proximal lower extremities in patients with suspected JDM 1, 2
Immediate laboratory testing is required, including Creatine kinase (CK), LDH, AST, ALT, with elevated levels >10x normal suggesting inflammatory myopathy 5, 4
Critical red flags requiring ICU evaluation include dysphagia, dysarthria, and respiratory muscle weakness 5, 4

The American Academy of Neurology states that Guillain-Barré Syndrome (GBS) typically presents with weakness beginning distally in one limb and ascending to other limbs, and is an immune-mediated process requiring urgent recognition 6
The Mayo Clinic recommends distinguishing GBS from other conditions by its ascending pattern and acute/subacute onset 6

The American Heart Association suggests that Peripheral Arterial Disease (PAD) is unlikely in adolescents unless diabetes and another atherosclerosis risk factor are present, and would present with claudication rather than chronic stiffness 9
The American College of Cardiology recommends considering vasculitis/connective tissue disease if systemic symptoms are present (fever, weight loss, rash) 9

The American Academy of Sleep Medicine states that Restless Legs Syndrome (RLS) is characterized by an urge to move legs with uncomfortable sensations, worsening during rest/inactivity and relieving with movement, and worsening in the evening/night 8
The Journal of the American Geriatrics Society recommends checking serum ferritin levels, with <50 ng/mL consistent with RLS and suggesting a need for iron supplementation 8

The European League Against Rheumatism (EULAR) recommends distinguishing stiffness from weakness, examining for skin manifestations, and assessing for red flags in the initial assessment 1, 2, 4
The American College of Rheumatology suggests performing essential laboratory tests, including CK, LDH, AST, ALT, and myositis-specific antibodies, and considering advanced imaging/biopsy if necessary 1, 2, 5, 7